ID   CAC1C_RABIT             Reviewed;        2171 AA.
AC   P15381; Q03716; Q28676; Q99243;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   03-APR-2013, entry version 112.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1C;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;
DE   AltName: Full=Smooth muscle calcium channel blocker receptor;
DE            Short=CACB-receptor;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.2;
GN   Name=CACNA1C; Synonyms=CACH2, CACN2, CACNL1A1, CCHL1A1;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
OC   Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   PubMed=2474130; DOI=10.1038/340230a0;
RA   Mikami A., Imoto K., Tanabe T., Ni Idomme T., Mori Y., Takeshima H.,
RA   Narumiya S., Numa S.;
RT   "Primary structure and functional expression of the cardiac
RT   dihydropyridine-sensitive calcium channel.";
RL   Nature 340:230-233(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart, and Lung;
RX   PubMed=2169433; DOI=10.1016/0014-5793(90)81205-3;
RA   Biel M., Ruth P., Bosse E., Hullin R., Stuehmer W., Flockerzi V.,
RA   Hoffmann F.;
RT   "Primary structure and functional expression of a high voltage
RT   activated calcium channel from rabbit lung.";
RL   FEBS Lett. 269:409-412(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-98 (ISOFORM 5).
RC   TISSUE=Heart muscle;
RX   PubMed=1652442; DOI=10.1111/j.1432-1033.1991.tb21051.x;
RA   Biel M., Hullin R., Freundner S., Singer D., Dascal N., Flockerzi V.,
RA   Hofmann F.;
RT   "Tissue-specific expression of high-voltage-activated dihydropyridine-
RT   sensitive L-type calcium channels.";
RL   Eur. J. Biochem. 200:81-88(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1192-1485 (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=2173707;
RA   Perez-Reyes E., Wei X., Castellano A., Birnbaumer L.;
RT   "Molecular diversity of L-type calcium channels. Evidence for
RT   alternative splicing of the transcripts of three non-allelic genes.";
RL   J. Biol. Chem. 265:20430-20436(1990).
RN   [5]
RP   MUTAGENESIS, AND CALCIUM-BINDING.
RX   PubMed=8232554; DOI=10.1038/366158a0;
RA   Yang J., Ellinor P.T., Sather W.A., Zhang J.-F., Tsien R.W.;
RT   "Molecular determinants of Ca2+ selectivity and ion permeation in L-
RT   type Ca2+ channels.";
RL   Nature 366:158-161(1993).
RN   [6]
RP   MUTAGENESIS OF CYS-168.
RX   PubMed=9502794;
RA   Ren D., Xu H., Eberl D.F., Chopra M., Hall L.M.;
RT   "A mutation affecting dihydropyridine-sensitive current levels and
RT   activation kinetics in Drosophila muscle and mammalian heart calcium
RT   channels.";
RL   J. Neurosci. 18:2335-2341(1998).
RN   [7]
RP   PHOSPHORYLATION BY PKA.
RX   PubMed=1325377; DOI=10.1016/0014-5793(92)80804-P;
RA   Yoshida A., Takahashi M., Nishimura S., Takeshima H., Kokubun S.;
RT   "Cyclic AMP-dependent phosphorylation and regulation of the cardiac
RT   dihydropyridine-sensitive Ca channel.";
RL   FEBS Lett. 309:343-349(1992).
RN   [8]
RP   BETA-SUBUNIT BINDING DOMAIN.
RX   PubMed=7509046; DOI=10.1038/368067a0;
RA   Pragnell M., de Waard M., Mori Y., Tanabe T., Snutch T.P.,
RA   Campbell K.P.;
RT   "Calcium channel beta-subunit binds to a conserved motif in the I-II
RT   cytoplasmic linker of the alpha 1-subunit.";
RL   Nature 368:67-70(1994).
RN   [9]
RP   EF-HAND MOTIF AND CALCIUM INACTIVATION.
RX   PubMed=7491499; DOI=10.1126/science.270.5241.1502;
RA   de Leon M., Wang Y., Jones L., Perez-Reyes E., Wei X., Soong T.W.,
RA   Snutch T.P., Yue D.T.;
RT   "Essential Ca(2+)-binding motif for Ca(2+)-sensitive inactivation of
RT   L-type Ca2+ channels.";
RL   Science 270:1502-1505(1995).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17525370; DOI=10.1161/CIRCRESAHA.106.146399;
RA   Yada H., Murata M., Shimoda K., Yuasa S., Kawaguchi H., Ieda M.,
RA   Adachi T., Murata M., Ogawa S., Fukuda K.;
RT   "Dominant negative suppression of Rad leads to QT prolongation and
RT   causes ventricular arrhythmias via modulation of L-type Ca2+ channels
RT   in the heart.";
RL   Circ. Res. 101:69-77(2007).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1C
CC       gives rise to L-type calcium currents. Long-lasting (L-type)
CC       calcium channels belong to the 'high-voltage activated' (HVA)
CC       group. They are blocked by dihydropyridines (DHP),
CC       phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA
CC       (omega-Aga-IIIA). They are however insensitive to omega-conotoxin-
CC       GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA).
CC       Calcium channels containing the alpha-1C subunit play an important
CC       role in excitation-contraction coupling in the heart. Binding of
CC       calmodulin or CABP1 at the same regulatory sites results in an
CC       opposit effects on the channel function (By similarity).
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity.
CC       Interacts with CABP1 and CACNA2D4 (By similarity). Interacts (via
CC       C-terminal CDB motif) with CABP5; in a calcium-dependent manner
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Cell
CC       membrane. Note=The interaction between RRAD and CACNB2 regulates
CC       its trafficking to the cell membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist;
CC       Name=1; Synonyms=CACH2A;
CC         IsoId=P15381-1; Sequence=Displayed;
CC       Name=2; Synonyms=CACH2C;
CC         IsoId=P15381-2; Sequence=VSP_000906;
CC       Name=3; Synonyms=CACH2D;
CC         IsoId=P15381-3; Sequence=VSP_000907;
CC       Name=4; Synonyms=Lung;
CC         IsoId=P15381-4; Sequence=VSP_000902, VSP_000904, VSP_000905,
CC                                  VSP_000906;
CC       Name=5; Synonyms=C141;
CC         IsoId=P15381-5; Sequence=VSP_000902, VSP_000903;
CC   -!- TISSUE SPECIFICITY: Expression in cardiac muscle. In lung,
CC       expressed in airway and vascular smooth muscle cells.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- DOMAIN: Binding of intracellular calcium through the EF-hand motif
CC       inhibits the opening of the channel.
CC   -!- PTM: Phosphorylation by PKA activates the channel.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit
CC       (TC 1.A.1.11) family. CACNA1C subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X15539; CAA33546.1; -; mRNA.
DR   EMBL; X55763; CAA39289.1; -; mRNA.
DR   EMBL; X60782; CAA43196.1; -; mRNA.
DR   EMBL; M57974; AAA31182.1; -; mRNA.
DR   PIR; S05054; S05054.
DR   PIR; S11339; S11339.
DR   RefSeq; NP_001129994.1; NM_001136522.1.
DR   UniGene; Ocu.1835; -.
DR   UniGene; Ocu.3254; -.
DR   PDB; 4DEY; X-ray; 1.95 A; B=435-539.
DR   PDBsum; 4DEY; -.
DR   ProteinModelPortal; P15381; -.
DR   SMR; P15381; 1642-1670.
DR   GeneID; 100101555; -.
DR   CTD; 100101555; -.
DR   eggNOG; COG1226; -.
DR   HOVERGEN; HBG050763; -.
DR   BindingDB; P15381; -.
DR   ChEMBL; CHEMBL2830; -.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; ISS:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0007204; P:elevation of cytosolic calcium ion concentration; ISS:UniProtKB.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005451; VDCC_L_a1csu.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF47; PTHR10037:SF47; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   PRINTS; PR01635; LVDCCALPHA1C.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Metal-binding;
KW   Phosphoprotein; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   2171       Voltage-dependent L-type calcium channel
FT                                subunit alpha-1C.
FT                                /FTId=PRO_0000053930.
FT   TOPO_DOM      1    154       Cytoplasmic (Potential).
FT   TRANSMEM    155    173       Helical; Name=S1 of repeat I.
FT   TOPO_DOM    174    190       Extracellular (Potential).
FT   TRANSMEM    191    211       Helical; Name=S2 of repeat I.
FT   TOPO_DOM    212    223       Cytoplasmic (Potential).
FT   TRANSMEM    224    242       Helical; Name=S3 of repeat I.
FT   TOPO_DOM    243    262       Extracellular (Potential).
FT   TRANSMEM    263    281       Helical; Name=S4 of repeat I.
FT   TOPO_DOM    282    300       Cytoplasmic (Potential).
FT   TRANSMEM    301    320       Helical; Name=S5 of repeat I.
FT   TOPO_DOM    321    410       Extracellular (Potential).
FT   TRANSMEM    411    435       Helical; Name=S6 of repeat I.
FT   TOPO_DOM    436    554       Cytoplasmic (Potential).
FT   TRANSMEM    555    573       Helical; Name=S1 of repeat II.
FT   TOPO_DOM    574    588       Extracellular (Potential).
FT   TRANSMEM    589    608       Helical; Name=S2 of repeat II.
FT   TOPO_DOM    609    616       Cytoplasmic (Potential).
FT   TRANSMEM    617    635       Helical; Name=S3 of repeat II.
FT   TOPO_DOM    636    645       Extracellular (Potential).
FT   TRANSMEM    646    664       Helical; Name=S4 of repeat II.
FT   TOPO_DOM    665    683       Cytoplasmic (Potential).
FT   TRANSMEM    684    703       Helical; Name=S5 of repeat II.
FT   TOPO_DOM    704    758       Extracellular (Potential).
FT   TRANSMEM    759    783       Helical; Name=S6 of repeat II.
FT   TOPO_DOM    784    930       Cytoplasmic (Potential).
FT   TRANSMEM    931    949       Helical; Name=S1 of repeat III.
FT   TOPO_DOM    950    965       Extracellular (Potential).
FT   TRANSMEM    966    985       Helical; Name=S2 of repeat III.
FT   TOPO_DOM    986    997       Cytoplasmic (Potential).
FT   TRANSMEM    998   1016       Helical; Name=S3 of repeat III.
FT   TOPO_DOM   1017   1023       Extracellular (Potential).
FT   TRANSMEM   1024   1042       Helical; Name=S4 of repeat III.
FT   TOPO_DOM   1043   1061       Cytoplasmic (Potential).
FT   TRANSMEM   1062   1081       Helical; Name=S5 of repeat III.
FT   TOPO_DOM   1082   1171       Extracellular (Potential).
FT   TRANSMEM   1172   1196       Helical; Name=S6 of repeat III.
FT   TOPO_DOM   1197   1249       Cytoplasmic (Potential).
FT   TRANSMEM   1250   1268       Helical; Name=S1 of repeat IV.
FT   TOPO_DOM   1269   1283       Extracellular (Potential).
FT   TRANSMEM   1284   1303       Helical; Name=S2 of repeat IV.
FT   TOPO_DOM   1304   1311       Cytoplasmic (Potential).
FT   TRANSMEM   1312   1330       Helical; Name=S3 of repeat IV.
FT   TOPO_DOM   1331   1354       Extracellular (Potential).
FT   TRANSMEM   1355   1373       Helical; Name=S4 of repeat IV.
FT   TOPO_DOM   1374   1392       Cytoplasmic (Potential).
FT   TRANSMEM   1393   1412       Helical; Name=S5 of repeat IV.
FT   TOPO_DOM   1413   1481       Extracellular (Potential).
FT   TRANSMEM   1482   1506       Helical; Name=S6 of repeat IV.
FT   TOPO_DOM   1507   2171       Cytoplasmic (Potential).
FT   REPEAT      141    438       I.
FT   REPEAT      540    786       II.
FT   REPEAT      917   1199       III.
FT   REPEAT     1236   1509       IV.
FT   CA_BIND    1535   1546
FT   REGION      458    475       Binding to the beta subunit (By
FT                                similarity).
FT   REGION     1119   1209       Dihydropyridine binding (By similarity).
FT   REGION     1460   1517       Dihydropyridine binding (By similarity).
FT   REGION     1474   1520       Phenylalkylamine binding (By similarity).
FT   COMPBIAS    684    690       Poly-Leu.
FT   COMPBIAS    798    804       Poly-Glu.
FT   COMPBIAS   1177   1183       Poly-Ile.
FT   SITE        393    393       Calcium ion selectivity and permeability.
FT   SITE        736    736       Calcium ion selectivity and permeability.
FT   SITE       1145   1145       Calcium ion selectivity and permeability.
FT   SITE       1446   1446       Calcium ion selectivity and permeability.
FT   MOD_RES     845    845       Phosphoserine (By similarity).
FT   MOD_RES    1517   1517       Phosphoserine; by PKA (Potential).
FT   MOD_RES    1920   1920       Phosphoserine; by PKA (Potential).
FT   MOD_RES    1928   1928       Phosphoserine; by PKA (Potential).
FT   CARBOHYD    183    183       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    358    358       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1418   1418       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1469   1469       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ       1     46       MLRALVQPATPAYQPLPSHLSAETESTCKGTVVHEAQLNHF
FT                                YISPG -> MVNENTRMYIPEENHQ (in isoform 4
FT                                and isoform 5).
FT                                /FTId=VSP_000902.
FT   VAR_SEQ      66     79       Missing (in isoform 5).
FT                                /FTId=VSP_000903.
FT   VAR_SEQ     402    421       MQDAMGYELPWVYFVSLVIF -> VNDAVGRDWPWIYFVTL
FT                                III (in isoform 4).
FT                                /FTId=VSP_000904.
FT   VAR_SEQ     494    494       M -> RGTPAGLHAQKKGKFAWFSHSTETHV (in
FT                                isoform 4).
FT                                /FTId=VSP_000905.
FT   VAR_SEQ    1307   1334       GYFSDPWNVFDFLIVIGSIIDVILSETN -> HYFCDAWNT
FT                                FDALIVVGSIVDIAITEVH (in isoform 2 and
FT                                isoform 4).
FT                                /FTId=VSP_000906.
FT   VAR_SEQ    1335   1345       Missing (in isoform 3).
FT                                /FTId=VSP_000907.
FT   MUTAGEN     168    168       C->G: Small reduction of current
FT                                amplitude.
FT   MUTAGEN     168    168       C->K,W: No current.
FT   MUTAGEN     168    168       C->S: No effect.
FT   MUTAGEN     168    168       C->Y: Slower channel activation and
FT                                reduction of current amplitude.
FT   MUTAGEN     393    393       E->K: Drastic reduction of barium
FT                                permeability. Reduction of calcium block
FT                                of lithium currents.
FT   MUTAGEN     393    393       E->Q: Attenuates calcium block of inward
FT                                barium, lithium, or cadmium currents.
FT   MUTAGEN     736    736       E->K: Drastic reduction of barium
FT                                permeability. Reduction of calcium block
FT                                of lithium currents.
FT   MUTAGEN     736    736       E->Q: Attenuates calcium block of inward
FT                                barium, lithium, or cadmium currents.
FT   MUTAGEN    1145   1145       E->K: Drastic reduction of barium
FT                                permeability. Reduction of calcium block
FT                                of lithium currents.
FT   MUTAGEN    1145   1145       E->Q: Attenuates calcium block of inward
FT                                barium, lithium, or cadmium currents.
FT   MUTAGEN    1446   1446       E->K: Moderate reduction of barium
FT                                permeability. Reduction of calcium block
FT                                of lithium currents.
FT   MUTAGEN    1446   1446       E->Q: Attenuates calcium block of inward
FT                                barium, lithium, or cadmium currents.
FT   CONFLICT   1346   1346       N -> S (in Ref. 4; AAA31182).
FT   CONFLICT   1468   1468       H -> S (in Ref. 4; AAA31182).
FT   HELIX       451    475
SQ   SEQUENCE   2171 AA;  242784 MW;  B64F08F09D71C65D CRC64;
     MLRALVQPAT PAYQPLPSHL SAETESTCKG TVVHEAQLNH FYISPGGSNY GSPRPAHANM
     NANAAAGLAP EHIPTPGAAL SWQAAIDAAR QAKLMGSAGN ATISTVSSTQ RKRQQYGKPK
     KQGSTTATRP PRALLCLTLK NPIRRACISI VEWKPFEIII LLTIFANCVA LAIYIPFPED
     DSNATNSNLE RVEYLFLIIF TVEAFLKVIA YGLLFHPNAY LRNGWNLLDF IIVVVGLFSA
     ILEQATKADG ANALGGKGAG FDVKALRAFR VLRPLRLVSG VPSLQVVLNS IIKAMVPLLH
     IALLVLFVII IYAIIGLELF MGKMHKTCYN QEGVADVPAE DDPSPCALET GHGRQCQNGT
     VCKPGWDGPK HGITNFDNFA FAMLTVFQCI TMEGWTDVLY WMQDAMGYEL PWVYFVSLVI
     FGSFFVLNLV LGVLSGEFSK EREKAKARGD FQKLREKQQL EEDLKGYLDW ITQAEDIDPE
     NEDEGMDEEK PRNMSMPTSE TESVNTENVA GGDIEGENCG ARLAHRISKS KFSRYWRRWN
     RFCRRKCRAA VKSNVFYWLV IFLVFLNTLT IASEHYNQPH WLTEVQDTAN KALLALFTAE
     MLLKMYSLGL QAYFVSLFNR FDCFIVCGGI LETILVETKV MSPLGISVLR CVRLLRIFKI
     TRYWNSLSNL VASLLNSVRS IASLLLLLFL FIIIFSLLGM QLFGGKFNFD EMQTRRSTFD
     NFPQSLLTVF QILTGEDWNS VMYDGIMAYG GPSFPGMLVC IYFIILFICG NYILLNVFLA
     IAVDNLADAE SLTSAQKEEE EEKERKKLAR TASPEKKQEV VGKPALEEAK EEKIELKSIT
     ADGESPPTTK INMDDLQPNE SEDKSPYPNP ETTGEEDEEE PEMPVGPRPR PLSELHLKEK
     AVPMPEASAF FIFSPNNRFR LQCHRIVNDT IFTNLILFFI LLSSISLAAE DPVQHTSFRN
     HILFYFDIVF TTIFTIEIAL KMTAYGAFLH KGSFCRNYFN ILDLLVVSVS LISFGIQSSA
     INVVKILRVL RVLRPLRAIN RAKGLKHVVQ CVFVAIRTIG NIVIVTTLLQ FMFACIGVQL
     FKGKLYTCSD SSKQTEAECK GNYITYKDGE VDHPIIQPRS WENSKFDFDN VLAAMMALFT
     VSTFEGWPEL LYRSIDSHTE DKGPIYNYRV EISIFFIIYI IIIAFFMMNI FVGFVIVTFQ
     EQGEQEYKNC ELDKNQRQCV EYALKARPLR RYIPKNQHQY KVWYVVNSTY FEYLMFVLIL
     LNTICLAMQH YGQSCLFKIA MNILNMLFTG LFTVEMILKL IAFKPKGYFS DPWNVFDFLI
     VIGSIIDVIL SETNPAEHTQ CSPSMNAEEN SRISITFFRL FRVMRLVKLL SRGEGIRTLL
     WTFIKSFQAL PYVALLIVML FFIYAVIGMQ VFGKIALNDT TEINRNNNFQ TFPQAVLLLF
     RCATGEAWQD IMLACMPGKK CAPESEPHNS TEGETPCGSS FAVFYFISFY MLCAFLIINL
     FVAVIMDNFD YLTRDWSILG PHHLDEFKRI WAEYDPEAKG RIKHLDVVTL LRRIQPPLGF
     GKLCPHRVAC KRLVSMNMPL NSDGTVMFNA TLFALVRTAL RIKTEGNLEQ ANEELRAIIK
     KIWKRTSMKL LDQVVPPAGD DEVTVGKFYA TFLIQEYFRK FKKRKEQGLV GKPSQRNALS
     LQAGLRTLHD IGPEIRRAIS GDLTAEEELD KAMKEAVSAA SEDDIFRRAG GLFGNHVSYY
     QSDSRSAFPQ TFTTQRPLHI SKAGNNQGDT ESPSHEKLVD STFTPSSYSS TGSNANINNA
     NNTALGRLPR PAGYPSTVST VEGHGSPLSP AVRAQEAAWK LSSKRCHSQE SQIAMACQEG
     ASQDDNYDVR IGEDAECCSE PSLLSTEMLS YQDDENRQLA PPEEEKRDIR LSPKKGFLRS
     ASLGRRASFH LECLKRQKNQ GGDISQKTVL PLHLVHHQAL AVAGLSPLLQ RSHSPTSLPR
     PCATPPATPG SRGWPPQPIP TLRLEGADSS EKLNSSFPSI HCGSWSGENS PCRGDSSAAR
     RARPVSLTVP SQAGAQGRQF HGSASSLVEA VLISEGLGQF AQDPKFIEVT TQELADACDL
     TIEEMENAAD DILSGGARQS PNGTLLPFVN RRDPGRDRAG QNEQDASGAC APGCGQSEEA
     LADRRAGVSS L
//
